
One bold Wall Street call resets Nvidia’s upside potential
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

One bold Wall Street call resets Nvidia’s upside potential
Investing.com - U.S. inflation expectations remain anchored despite more than five years of above-target price pressures, according to a Goldman Sachs research note published on Monday.

One notable subtrend emerged at Monterey Car Week: At the very top of the market, manual transmission has become the height of fashion.

Costco is making it easier for members to get some of its most popular items without setting foot inside a warehouse.

Investors’ intense focus on AI is at times adding to the might of a small club of Big Tech stocks with mega market values to potentially make or break a single trading session for the S 500.

History says SpaceX shareholders will lose money in the coming months.

Prices have hardly budged where it counts for consumers, courtesy of Trump’s tariffs and the Iran war.
Investing.com -- Networking is replacing raw computing power as the main constraint on artificial intelligence performance as AI systems grow larger and more complex, Citi analysts said following the second day of the Hot Chips conference.
Investing.com -- Iran’s foreign trade has fallen nearly 35% under U.S. sanctions and a naval blockade, President Masoud Pezeshkian said, as Tehran’s leadership acknowledged mounting economic pressure six months into the war, Reuters reported exclusively.

On Friday, a federal appeals court blocked Kalshi from avoiding Nevada gaming oversight, intensifying a nationwide fight over who regulates the fast-growing prediction markets industry. Kalshi Faces Regulatory Setback as Courts Clash The 9th U.S. Circuit Court of Appeals ruled...

A multi-billion-dollar bet on the Louisiana coast could reshape how investors value the newly public rocket maker.

Solstice Advanced Materials (NASDAQ:SOLS) jumped by 12.76 percent on Friday to finish at $63.53 apiece after abandoning a plan to acquire Element Solutions for $14.5 billion, while investors also cheered a $500 million share buyback program. In a statement, the company said that it entered into an agreement with Element Solutions to formally terminate their […]

One stubborn forecast is drawing unusual heat across Wall Street.

Arch Aplin III, the CEO of Buc-ee’s travel centers and gas stations, has said that the company will seek expansion in “conservative” states following a trademark infringement lawsuit it filed against an Ohio convenience store. Arch Aplin III on Expanding...
Investing.com -- A White House teleprompter operator has settled a federal probe into wagers made using advance knowledge of President Donald Trump’s speeches, The Wall Street Journal reported Friday.

Bank of America sees a differentiated opportunity in a breakthrough sleep apnea pill.

For drugmakers, a clock starts before a drug is even approved: Patents run out, lower-priced copycats flood in and sales collapse. The pharma industry is entering its biggest wave of patent expirations in decades. The world’s bestselling drug in 2025, Merck’s cancer immunotherapy Keytruda, loses U.S. patent protection in 2028, and nearly every pharma company has at least one blockbuster drug that will go off patent in the next five years.

Record $659M profit driven by strong tanker rates across vessel classes.

Marvell Technology (NasdaqGS:MRVL) reported strong quarterly results and raised near term and long term revenue guidance, yet the stock fell after the earnings release. The company lifted its fiscal 2027 and 2028 revenue outlook, pointing to building momentum in data center demand and AI related growth drivers. The post earnings share price reaction highlighted that investor expectations for AI exposure remain very high, even when companies report solid operational performance. For a...

Associate Attorney General Stanley Woodward said federal pharmacy rules exist to protect the public and that profit cannot justify conduct that fuels the opioid epidemic.

SentinelOne (NYSE:S) reported second-quarter fiscal 2027 results that exceeded its guidance for revenue, operating income and earnings per share, as the cybersecurity company cited growth in artificial intelligence security, cloud and data offerings alongside continued endpoint demand. Revenue for

The Fed chair signals his commitment to bringing down inflation, boosting the chance of a September rate hike.

SentinelOne co-founder, chairman and CEO Tomer Weingarten discusses earnings and AI Cybersecurity in an interview with Romaine Bostick and Emily Graffeo on "The Close."
A software fix may be limiting investor concern
A collapsing legacy business is hiding rapid AI momentum
Marvell Stock Crashes Below Key Support After 10% Selloff
One number could reshape Workday's growth story

President Donald Trump is set to meet with US oil refining executives as he confronts persistently high gasoline prices stoked by the war in Iran.

The chipmaker beat on both lines Thursday, then watched its stock shed nearly 11% by Friday.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.